Lumos Pharma’s Patient-Centric Strategy for Rare Disease Drug Development
XTalks
JANUARY 23, 2024
Rare diseases, often overlooked in the broader medical research field, affect a small percentage of the population yet carry a significant burden for those diagnosed and their families. Pediatric growth hormone deficiency (PGHD) is one such condition, affecting a child’s growth and development.
Let's personalize your content